Peptide Based Vaccine Approaches for Cancer—A Novel Approach Using a WT-1 Synthetic Long Peptide and the IRX-2 Immunomodulatory Regimen

by James E. Egan, Paul H. Naylor, Neil L. Berinstein
Published 2011-10-01

Increased immune infiltration and chemokine receptor expression in head and neck epithelial tumors after neoadjuvant immunotherapy with the IRX-2 regimen

by Neil L. Berinstein, Michael McNamara, Ariane Nguyen, James Egan, Gregory T. Wolf
Published 2018-05-01